Overview

Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether TissueGene-C, an allogeneic human chondrocytes expressing Transforming Growth Factor(TGF)-b1, is effective and safe in patients with degenerative arthritis
Phase:
Phase 2
Details
Lead Sponsor:
Kolon Life Science